Baystate Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$70.8K Buy
1,224
+69
+6% +$3.68K 0.01% 321
2023
Q3
$61K Sell
1,155
-112
-9% -$5.87K 0.01% 315
2023
Q2
$68.5K Hold
1,267
0.01% 296
2023
Q1
$63.4K Buy
1,267
+112
+10% +$5.28K 0.01% 308
2022
Q4
$53K Hold
1,155
﹤0.01% 318
2022
Q3
$45K Hold
1,155
﹤0.01% 315
2022
Q2
$43K Hold
1,155
﹤0.01% 335
2022
Q1
$51K Sell
1,155
-106
-8% -$4.59K ﹤0.01% 315
2021
Q4
$54K Sell
1,261
-10
-0.8% -$420 ﹤0.01% 308
2021
Q3
$55K Buy
1,271
+106
+9% +$4.69K 0.01% 291
2021
Q2
$50K Hold
1,165
﹤0.01% 279
2021
Q1
$45K Hold
1,165
﹤0.01% 270
2020
Q4
$42K Hold
1,165
﹤0.01% 264
2020
Q3
$45K Buy
1,165
+450
+63% +$17.3K 0.01% 233
2020
Q2
$25K Buy
715
+705
+7,050% +$25.4K ﹤0.01% 283
2020
Q1
$0 Hold
10
﹤0.01% 609
2019
Q4
$0 Hold
10
﹤0.01% 624
2019
Q3
$0 Hold
10
﹤0.01% 580
2019
Q2
$1K Hold
10
﹤0.01% 540
2019
Q1
$1K Hold
10
﹤0.01% 551
2018
Q4
$1K Hold
10
﹤0.01% 556
2018
Q3
$1K Hold
10
﹤0.01% 572
2018
Q2
$1K Hold
10
﹤0.01% 591
2018
Q1
$1K Hold
10
﹤0.01% 551
2017
Q4
$1K Hold
10
﹤0.01% 554
2017
Q3
$1K Hold
10
﹤0.01% 538
2017
Q2
$1K Hold
10
﹤0.01% 556
2017
Q1
$1K Buy
+10
New +$243 ﹤0.01% 520

Other funds holding BSX

Baystate Wealth Management's BSX Position: Q4 2023 in Review

Baystate Wealth Management increased its Boston Scientific (BSX) stake by 6% in Q4 2023, buying an estimated $3.68K and bringing the position to 1,224 shares worth $70.8K. The position accounts for 0.01% of the portfolio, ranked #321.

Baystate Wealth Management first reported a position in BSX in Q1 2017 and has held it in 28 quarters since. 1,150 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • Baystate Wealth Management held 1,224 shares of Boston Scientific worth $70.8K as of Q4 2023.
  • Baystate Wealth Management bought 69 Boston Scientific shares in Q4 2023, an estimated $3.68K.
  • Boston Scientific made up 0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #321 holding.
  • Baystate Wealth Management first reported a position in Boston Scientific in Q1 2017 and has held it in 28 quarters since.
  • 1,150 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.